Cargando…
Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection
Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGRO...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366571/ https://www.ncbi.nlm.nih.gov/pubmed/34373441 http://dx.doi.org/10.12659/AJCR.932544 |
_version_ | 1783738908066971648 |
---|---|
author | Alshaya, Omar A. Saleh, Rana A. Alshehri, Shaden D. |
author_facet | Alshaya, Omar A. Saleh, Rana A. Alshehri, Shaden D. |
author_sort | Alshaya, Omar A. |
collection | PubMed |
description | Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited to voriconazole and liposomal amphotericin B. Drug-induced liver injury (DILI) by 1 of these 2 antifungal agents further complicates the management of these infections. CASE REPORT: A 38-year-old woman with short bowel syndrome presented to the hospital with concerns of abdominal pain and loose stools. An abdominal CT was negative for inflammatory or ischemic bowel disease, and there was no evidence of liver disease. She tested positive for SARS-CoV-2 and required transfer to the ICU due to hypotension requiring fluid resuscitation and vasopressors. On day 43 of her admission, the patient developed a low-grade fever, for which she underwent central-line and peripheral-blood cultures that were positive for Fusarium dimerum. The central line was removed and i.v. voriconazole was started. After 3 days of treatment, the patient’s liver enzymes rose abruptly. Voriconazole was discontinued and replaced with liposomal amphotericin B, and the liver enzymes improved significantly. The patient completed 14 days of therapy and was discharged from the hospital. CONCLUSIONS: This is a case of F. dimerum infection followed by DILI from voriconazole treatment. Her infection was resolved after switching to liposomal amphotericin B, with improvement in liver enzymes on day 1 after discontinuing voriconazole. This observation demonstrates that altering antifungal classes may be an appropriate strategy when confronted with DILI. |
format | Online Article Text |
id | pubmed-8366571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83665712021-08-25 Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection Alshaya, Omar A. Saleh, Rana A. Alshehri, Shaden D. Am J Case Rep Articles Patient: Female, 38-year-old Final Diagnosis: Drug induced liver injury Symptoms: Fever • abdominal pain • nausea and vomiting • loose stools Medication: — Clinical Procedure: — Specialty: Infectious Diseases • General and Internal Medicine • Pharmacology and Pharmacy OBJECTIVE: Rare disease BACKGROUND: Fusarium spp. is a rare cause of opportunistic life-threatening fungal infections. It has a remarkably high resistance profile with few effective antifungal agents, mostly limited to voriconazole and liposomal amphotericin B. Drug-induced liver injury (DILI) by 1 of these 2 antifungal agents further complicates the management of these infections. CASE REPORT: A 38-year-old woman with short bowel syndrome presented to the hospital with concerns of abdominal pain and loose stools. An abdominal CT was negative for inflammatory or ischemic bowel disease, and there was no evidence of liver disease. She tested positive for SARS-CoV-2 and required transfer to the ICU due to hypotension requiring fluid resuscitation and vasopressors. On day 43 of her admission, the patient developed a low-grade fever, for which she underwent central-line and peripheral-blood cultures that were positive for Fusarium dimerum. The central line was removed and i.v. voriconazole was started. After 3 days of treatment, the patient’s liver enzymes rose abruptly. Voriconazole was discontinued and replaced with liposomal amphotericin B, and the liver enzymes improved significantly. The patient completed 14 days of therapy and was discharged from the hospital. CONCLUSIONS: This is a case of F. dimerum infection followed by DILI from voriconazole treatment. Her infection was resolved after switching to liposomal amphotericin B, with improvement in liver enzymes on day 1 after discontinuing voriconazole. This observation demonstrates that altering antifungal classes may be an appropriate strategy when confronted with DILI. International Scientific Literature, Inc. 2021-08-10 /pmc/articles/PMC8366571/ /pubmed/34373441 http://dx.doi.org/10.12659/AJCR.932544 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Articles Alshaya, Omar A. Saleh, Rana A. Alshehri, Shaden D. Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title | Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title_full | Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title_fullStr | Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title_full_unstemmed | Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title_short | Voriconazole-Induced Hepatotoxicity Resolved after Switching to Amphotericin B in Fusarium dimerum Central Line-Associated Bloodstream Infection |
title_sort | voriconazole-induced hepatotoxicity resolved after switching to amphotericin b in fusarium dimerum central line-associated bloodstream infection |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366571/ https://www.ncbi.nlm.nih.gov/pubmed/34373441 http://dx.doi.org/10.12659/AJCR.932544 |
work_keys_str_mv | AT alshayaomara voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection AT salehranaa voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection AT alshehrishadend voriconazoleinducedhepatotoxicityresolvedafterswitchingtoamphotericinbinfusariumdimerumcentrallineassociatedbloodstreaminfection |